Stereotactic radiosurgery for residual neurocytoma. Report of four cases.
The purpose of this report was to review the results of stereotactic radiosurgery in the management of patients with residual neurocytomas after initial resection or biopsy procedures. Four patients underwent stereotactic radiosurgery for histologically proven neurocytoma. Clinical and imaging studies were performed to evaluate the response to treatment. Radiosurgery was performed to deliver doses to the tumor margin of 14, 15, 16, and 20 Gy, depending on tumor volume and proximity to critical adjacent structures. More than 3 years later, imaging studies revealed significant reductions in tumor size. No new neurological deficits were identified at 53, 50, 42, and 38 months of follow up. The authors' initial experience shows that stereotactic radiosurgery appears to be an effective treatment for neurocytoma.
Tyler-Kabara
E
E
Department of Neurological Surgery, University of Pittsburgh, Pennsylvania, USA.
Kondziolka
D
D
Flickinger
J C
JC
Lunsford
L D
LD
D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000601:surgery*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual / Q000601:surgery*; D018306:Neurocytoma / Q000601:surgery*; D016634:Radiosurgery; D013238:Stereotaxic Techniques; D016896:Treatment Outcome